Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.
3.

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus.

Fåhraeus R, Rymo L, Rhim JS, Klein G.

Nature. 1990 May 31;345(6274):447-9.

PMID:
1692971
4.

Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.

Cuomo L, Trivedi P, de Campos-Lima PO, Zhang QJ, Ragnar E, Klein G, Masucci MG.

Mol Immunol. 1993 Apr;30(5):441-50.

PMID:
7681932
5.

The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells.

Niedobitek G, Fahraeus R, Herbst H, Latza U, Ferszt A, Klein G, Stein H.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;62(1):55-9.

PMID:
1352076
6.
7.

Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.

Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E.

J Immunol Methods. 2012 Nov 30;385(1-2):60-70. doi: 10.1016/j.jim.2012.08.008. Epub 2012 Aug 18.

PMID:
22921685
8.

Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1.

Lu JJ, Chen JY, Hsu TY, Yu WC, Su IJ, Yang CS.

J Gen Virol. 1996 Aug;77 ( Pt 8):1883-92.

PMID:
8760440
9.

Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1.

Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G.

Oncogene. 1993 Jun;8(6):1575-83.

PMID:
8389032
10.
11.

Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.

Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I.

J Virol. 1991 Mar;65(3):1558-67.

12.

Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.

Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.

J Cell Biochem. 2004 Mar 1;91(4):777-85.

PMID:
14991769
13.

Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.

Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB.

J Virol. 1988 Oct;62(10):3747-55.

14.

Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E.

J Virol. 1988 Nov;62(11):4173-84.

15.

Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination.

Walter J, Schirrmacher V, Mosier D.

Int J Cancer. 1995 May 4;61(3):363-9. Erratum in: Int J Cancer 1995 Oct 9;63(2):318.

PMID:
7537255
16.
18.

Epstein-Barr virus-encoded LMP-1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins.

Pokrovskaja K, Trivedi P, Klein G, Szekely L.

J Gen Virol. 1997 Aug;78 ( Pt 8):2031-40.

PMID:
9267004
19.

Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells.

Nicholson LJ, Hopwood P, Johannessen I, Salisbury JR, Codd J, Thorley-Lawson D, Crawford DH.

Oncogene. 1997 Jul 17;15(3):275-83.

20.

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation.

Dawson CW, Rickinson AB, Young LS.

Nature. 1990 Apr 19;344(6268):777-80.

PMID:
2158628

Supplemental Content

Support Center